Phase II study of forodesine hydrochloride in patients with advanced, fludarabine-refractory chronic lymphocytic leukemia (CLL).
Phase of Trial: Phase II
Latest Information Update: 07 Feb 2012
At a glance
- Drugs Forodesine (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 20 Jan 2012 Actual patient number is 8 according to ClinicalTrials.gov.
- 30 Sep 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 17 Dec 2009 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.